| 摘要 |
<p>A pharmaceutical composition containing as active ingredient 5-aminosalicylic acid or a pharmaceutically acceptable salt or ester thereof allows the treatment of colitis ulcerosa or Crohn"s disease by oral administration. A particular slow-release tablet formulation and its preparation are disclosed. </p> |
